These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 23117442)

  • 1. Incidence of severe asthmatic reactions after challenge exposure to occupational agents.
    Vandenplas O; D'Alpaos V; Evrard G; Jamart J
    Chest; 2013 May; 143(5):1261-1268. PubMed ID: 23117442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhalation challenges with occupational agents: threshold duration of exposure.
    D'Alpaos V; Vandenplas O; Evrard G; Jamart J
    Respir Med; 2013 May; 107(5):739-44. PubMed ID: 23415625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do Low Molecular Weight Agents Cause More Severe Asthma than High Molecular Weight Agents?
    Meca O; Cruz MJ; Sánchez-Ortiz M; González-Barcala FJ; Ojanguren I; Munoz X
    PLoS One; 2016; 11(6):e0156141. PubMed ID: 27280473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different Severity and Severity Predictors in Early-Onset and Late-Onset Asthma: A Taiwanese Population-Based Study.
    Wu TJ; Chen BY; Lee YL; Hsiue TR; Wu CF; Guo YL
    Respiration; 2015; 90(5):384-92. PubMed ID: 26418355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SABINA: An Overview of Short-Acting β
    Janson C; Menzies-Gow A; Nan C; Nuevo J; Papi A; Quint JK; Quirce S; Vogelmeier CF
    Adv Ther; 2020 Mar; 37(3):1124-1135. PubMed ID: 31981105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
    Blanchette CM; Culler SD; Ershoff D; Gutierrez B
    Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of occupational exposures on exacerbation of asthma: a population-based asthma cohort study.
    Kim JL; Henneberger PK; Lohman S; Olin AC; Dahlman-Höglund A; Andersson E; Torén K; Holm M
    BMC Pulm Med; 2016 Nov; 16(1):148. PubMed ID: 27842581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asthma severity and exposure to occupational asthmogens.
    Le Moual N; Siroux V; Pin I; Kauffmann F; Kennedy SM;
    Am J Respir Crit Care Med; 2005 Aug; 172(4):440-5. PubMed ID: 15961697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug utilization and asthma control among young Danish adults with asthma. Analyses of trends and determinants.
    Davidsen JR
    Dan Med J; 2012 Aug; 59(8):B4501. PubMed ID: 22849986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific inhalation challenge: the relationship between response, clinical variables and lung function.
    Hu C; Cruz MJ; Ojanguren I; de Homdedeu M; Gonzalez-Barcala FJ; Munoz X
    Occup Environ Med; 2017 Aug; 74(8):586-591. PubMed ID: 28270447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct temporal patterns of immediate asthmatic reactions due to high- and low-molecular-weight agents.
    Malo JL; Ghezzo H; L'archevêque J
    Clin Exp Allergy; 2012 Jul; 42(7):1021-7. PubMed ID: 22702501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double trouble: impact of inappropriate use of asthma medication on the use of health care resources.
    Anis AH; Lynd LD; Wang XH; King G; Spinelli JJ; Fitzgerald M; Bai T; Paré P
    CMAJ; 2001 Mar; 164(5):625-31. PubMed ID: 11258208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occupational asthma phenotypes identified by increased fractional exhaled nitric oxide after exposure to causal agents.
    Lemiere C; NGuyen S; Sava F; D'Alpaos V; Huaux F; Vandenplas O
    J Allergy Clin Immunol; 2014 Nov; 134(5):1063-7. PubMed ID: 25262466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five-fold increase in use of inhaled corticosteroids over 18 years in the general adult population in west Sweden.
    Ekerljung L; Bjerg A; Bossios A; Axelsson M; Torén K; Wennergren G; Lötvall J; Lundbäck B
    Respir Med; 2014 May; 108(5):685-93. PubMed ID: 24685491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
    Ye X; Gutierrez B; Zarotsky V; Nelson M; Blanchette CM
    Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asthma pharmacotherapy.
    Schofield ML
    Otolaryngol Clin North Am; 2014 Feb; 47(1):55-64. PubMed ID: 24286679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Principal findings of systematic reviews of acute asthma treatment in childhood.
    Castro-Rodriguez JA; J Rodrigo G; E Rodríguez-Martínez C
    J Asthma; 2015; 52(10):1038-45. PubMed ID: 26303207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of multicategory exposure marginal structural models to investigate the association between long-acting beta-agonists and prescribing of oral corticosteroids for asthma exacerbations in the Clinical Practice Research Datalink.
    Ali AK; Hartzema AG; Winterstein AG; Segal R; Lu X; Hendeles L
    Value Health; 2015 Mar; 18(2):260-70. PubMed ID: 25773561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with inhaled mometasone furoate reduces short-acting β(2) agonist claims and increases adherence compared to fluticasone propionate in asthma patients.
    Navaratnam P; Friedman HS; Urdaneta E
    Value Health; 2011; 14(2):339-46. PubMed ID: 21402302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of congenital malformations for asthmatic pregnant women using a long-acting β₂-agonist and inhaled corticosteroid combination versus higher-dose inhaled corticosteroid monotherapy.
    Eltonsy S; Forget A; Beauchesne MF; Blais L
    J Allergy Clin Immunol; 2015 Jan; 135(1):123-30. PubMed ID: 25226849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.